OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Microbiology Reviews is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)

Article	Citations
Antimicrobial Resistance in ESKAPE Pathogens	684
Coronavirus Disease 2019–COVID-19	605
Aspergillus fumigatus and Aspergillosis in 2019	424
Epidemiology of β-Lactamase-Producing Pathogens	352
The Global Ascendency of OXA-48-Type Carbapenemases	221
Emerging Tick-Borne Diseases	199
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy	185
New β-Lactam–β-Lactamase Inhibitor Combinations	184
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	155
Remdesivir against COVID-19 and Other Viral Diseases	154
Chagas Disease in the United States: a Public Health Approach	128
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	120
Laboratory Diagnosis of Human Brucellosis	110
Antifungal Susceptibility Testing: Current Approaches	103
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	92
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	87
Host-Directed Antiviral Therapy	83
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	83
Convalescent Plasma Therapy for COVID-19: State of the Art	82
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries	82
Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem	82
Human Melioidosis	81
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	77
Yersinia pestis: the Natural History of Plague	68
Microsporidiosis in Humans	65

Pathogenesis of Gram-Negative Bacteremia	63
Tuberculosis Vaccine Development: Progress in Clinical Evaluation	58
Viral Respiratory Pathogens and Lung Injury	56
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies	53
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	53
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	52
Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters	52
Evolutionary Pathways and Trajectories in Antibiotic Resistance	51
Laboratory Diagnosis of Lyme Borreliosis	50
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	50
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products	50
Advances in the Microbiology of Stenotrophomonas maltophilia	48
Intrathecal Antibacterial and Antifungal Therapies	45
SARS-CoV-2 Antiviral Therapy	45
Pathogenesis of Respiratory Viral and Fungal Coinfections	43
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	43
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	43
Taenia solium Cysticercosis and Its Impact in Neurological Disease	42